|
| 36753561 | Anti-merozoite antibodies induce natural killer cell effector function and are associated with immunity against malaria. | Sci Transl Med | 2023 |
| 37563050 | Preliminary studies on the immunogenicity of a prime-and-trap malaria vaccine in nonhuman primates. | Vaccine | 2023 |
| 37609210 | Ultra-low volume intradermal administration of radiation-attenuated sporozoites with the glycolipid adjuvant 7DW8-5 completely protects mice against malaria. | Res Sq | 2023 |
| 37571809 | Sporozoite immunization: innovative translational science to support the fight against malaria. | Expert Rev Vaccines | 2023 |
| 38093306 | Plasmodium knowlesi in pig-tailed macaques: a potential new model for malaria vaccine research. | Malar J | 2023 |
| 37160281 | Safety and Immunogenicity of Radiation-Attenuated PfSPZ Vaccine in Equatoguinean Infants, Children, and Adults. | Am J Trop Med Hyg | 2023 |
| 37082831 | Molecular and functional properties of human Plasmodium falciparum CSP C-terminus antibodies. | EMBO Mol Med | 2023 |
| 37384799 | The exception that proves the rule: Virulence gene expression at the onset of Plasmodium falciparum blood stage infections. | PLoS Pathog | 2023 |
| 37310872 | The Dantu blood group prevents parasite growth <i>in vivo</i>: Evidence from a controlled human malaria infection study. | Elife | 2023 |
| 37265668 | <i>Plasmodium</i> 18S Ribosomal RNA Biomarker Clearance After Food and Drug Administration-Approved Antimalarial Treatment in Controlled Human Malaria Infection Trials. | Open Forum Infect Dis | 2023 |
| 34801112 | Safety and efficacy of a three-dose regimen of Plasmodium falciparum sporozoite vaccine in adults during an intense malaria transmission season in Mali: a randomised, controlled phase 1 trial. | Lancet Infect Dis | 2022 |
| 35641527 | Efficacy, T cell activation and antibody responses in accelerated Plasmodium falciparum sporozoite chemoprophylaxis vaccine regimens. | NPJ Vaccines | 2022 |
| 35697668 | Plasmodium falciparum 7G8 challenge provides conservative prediction of efficacy of PfNF54-based PfSPZ Vaccine in Africa. | Nat Commun | 2022 |
| 35715803 | Cellular and antibody response in GMZ2-vaccinated Gabonese volunteers in a controlled human malaria infection trial. | Malar J | 2022 |
| 35687696 | Clonal evolution and TCR specificity of the human T<sub>FH</sub> cell response to <i>Plasmodium falciparum</i> CSP. | Sci Immunol | 2022 |
| 36477528 | In vitro production of infectious Plasmodium falciparum sporozoites. | Nature | 2022 |
| 36475905 | A randomized controlled trial showing safety and efficacy of a whole sporozoite vaccine against endemic malaria. | Sci Transl Med | 2022 |
| 36671393 | Sex-Specific Differences in Cytokine Induction by the Glycolipid Adjuvant 7DW8-5 in Mice. | Biomolecules | 2022 |
| 35999221 | A PfSPZ vaccine immunization regimen equally protective against homologous and heterologous controlled human malaria infection. | NPJ Vaccines | 2022 |
| 35928033 | PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial. | EClinicalMedicine | 2022 |
| 36030292 | Efficient infection of non-human primates with purified, cryopreserved Plasmodium knowlesi sporozoites. | Malar J | 2022 |
| 35922467 | Immunological profiles associated with distinct parasitemic states in volunteers undergoing malaria challenge in Gabon. | Sci Rep | 2022 |
| 36389797 | Increased levels of anti-PfCSP antibodies in post-pubertal females versus males immunized with PfSPZ Vaccine does not translate into increased protective efficacy. | Front Immunol | 2022 |
| 35226868 | Cryopreserved Sporozoites with and without the Glycolipid Adjuvant 7DW8-5 Protect in Prime-and-Trap Malaria Vaccination. | Am J Trop Med Hyg | 2022 |
| 35130487 | Multi-Dose Priming Regimens of PfSPZ Vaccine: Safety and Efficacy against Controlled Human Malaria Infection in Equatoguinean Adults. | Am J Trop Med Hyg | 2022 |
| 35242146 | A First for Human Vaccinology: GMP Compliant Radiation Attenuation of <i>Plasmodium falciparum</i> Sporozoites for Production of a Vaccine Against Malaria. | Front Immunol | 2022 |
| 34997079 | Cryopreservation of Anopheles stephensi embryos. | Sci Rep | 2022 |
| 35331251 | Diagnostic performance and comparison of ultrasensitive and conventional rapid diagnostic test, thick blood smear and quantitative PCR for detection of low-density Plasmodium falciparum infections during a controlled human malaria infection study in Equatorial Guinea. | Malar J | 2022 |
| 34710239 | An efficient single-cell based method for linking human T cell phenotype to T cell receptor sequence and specificity. | Eur J Immunol | 2022 |
| 33438712 | Nanotechnological immunoassay for rapid label-free analysis of candidate malaria vaccines. | Nanoscale | 2021 |
| 33713652 | Plasmodium falciparum LipB mutants display altered redox and carbon metabolism in asexual stages and cannot complete sporogony in Anopheles mosquitoes. | Int J Parasitol | 2021 |
| 33567273 | Atypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humans. | Cell Rep | 2021 |
| 33815377 | Expansion of Functional Myeloid-Derived Suppressor Cells in Controlled Human Malaria Infection. | Front Immunol | 2021 |
| 33888898 | Systems analysis and controlled malaria infection in Europeans and Africans elucidate naturally acquired immunity. | Nat Immunol | 2021 |
| 33499880 | Role of human Pegivirus infections in whole Plasmodium falciparum sporozoite vaccination and controlled human malaria infection in African volunteers. | Virol J | 2021 |
| 33746641 | A Mosquito Pick-and-Place System for PfSPZ-based Malaria Vaccine Production. | IEEE Trans Autom Sci Eng | 2021 |
| 34518679 | Safety, immunogenicity and efficacy of PfSPZ Vaccine against malaria in infants in western Kenya: a double-blind, randomized, placebo-controlled phase 2 trial. | Nat Med | 2021 |
| 34518543 | Immunoprofiles associated with controlled human malaria infection and naturally acquired immunity identify a shared IgA pre-erythrocytic immunoproteome. | NPJ Vaccines | 2021 |
| 34784388 | Knockout of Anopheles stephensi immune gene LRIM1 by CRISPR-Cas9 reveals its unexpected role in reproduction and vector competence. | PLoS Pathog | 2021 |
| 34243763 | Early whole blood transcriptional responses to radiation-attenuated Plasmodium falciparum sporozoite vaccination in malaria naïve and malaria pre-exposed adult volunteers. | Malar J | 2021 |
| 34174879 | Transient knockdown of Anopheles stephensi LRIM1 using RNAi increases Plasmodium falciparum sporozoite salivary gland infections. | Malar J | 2021 |
| 34061838 | Exploratory analysis of the effect of helminth infection on the immunogenicity and efficacy of the asexual blood-stage malaria vaccine candidate GMZ2. | PLoS Negl Trop Dis | 2021 |
| 34170120 | Identification of the Glycan Binding Profile of Human and Rodent <i>Plasmodium</i> Sporozoites. | ACS Infect Dis | 2021 |
| 34284778 | Incidence of Plasmodium falciparum malaria infection in 6-month to 45-year-olds on selected areas of Bioko Island, Equatorial Guinea. | Malar J | 2021 |
| 34194041 | Two chemoattenuated PfSPZ malaria vaccines induce sterile hepatic immunity. | Nature | 2021 |
| 33947856 | Heterologous protection against malaria by a simple chemoattenuated PfSPZ vaccine regimen in a randomized trial. | Nat Commun | 2021 |
| 34048504 | PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection. | PLoS Pathog | 2021 |
| 31402382 | Serologic Markers of Previous Malaria Exposure and Functional Antibodies Inhibiting Parasite Growth Are Associated With Parasite Kinetics Following a Plasmodium falciparum Controlled Human Infection. | Clin Infect Dis | 2020 |
| 31808594 | Ivermectin for causal malaria prophylaxis: a randomised controlled human infection trial. | Trop Med Int Health | 2020 |
| 32102854 | Recombinase Polymerase Amplification and Lateral Flow Assay for Ultrasensitive Detection of Low-Density Plasmodium falciparum Infection from Controlled Human Malaria Infection Studies and Naturally Acquired Infections. | J Clin Microbiol | 2020 |